{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:51Z","timestamp":1787003691566,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hybrid molecules maintain their stronghold in the drug market, with over 60% of drug candidates in pharmaceutical industries. The substantial expenses for developing and producing biologically privileged drugs are expected to create opportunities for producing hybrid molecule-based drugs. Therefore, we have developed a simple and efficient copper-catalyzed approach for synthesizing a wide range of triazole-linked glycohybrids derived from pyrazolo[1,5-\n                    <jats:italic>a<\/jats:italic>\n                    ]pyrimidines. Employing a microwave-assisted copper-catalyzed approach, we developed a concise route using various 7-\n                    <jats:italic>O<\/jats:italic>\n                    -propargylated pyrazolo[1,5-\n                    <jats:italic>a<\/jats:italic>\n                    ]pyrimidines and 1-azidoglycosides. This strategy afforded a series of twenty-seven glycohybrids up to 98% yield with diverse stereochemistry. All were achieved within a remarkably shortened time frame. Our investigation extends to evaluating the anticancer potential of these synthesized triazole-linked pyrazolo[1,5-\n                    <jats:italic>a<\/jats:italic>\n                    ] pyrimidine-based glycohybrids. In-vitro assays against MCF-7, MDA-MB231, and MDA-MB453 cell lines reveal intriguing findings. (\n                    <jats:italic>2R,3S,4S,5R,6R<\/jats:italic>\n                    )-2-(acetoxymethyl)-6-(4-(((5-(4-chlorophenyl)pyrazolo[1,5-\n                    <jats:italic>a<\/jats:italic>\n                    ]pyrimidin-7-yl)oxy)methyl)-1\n                    <jats:italic>H<\/jats:italic>\n                    -1,2,3-triazol-1-yl)tetrahydro-2\n                    <jats:italic>H<\/jats:italic>\n                    -pyran-3,4,5-triyl triacetate emerges as a standout with better anticancer activity against MDA-MB231 cells (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u200929.1\u00a0\u00b5M), while (\n                    <jats:italic>2R,3R,4S,5R,6R<\/jats:italic>\n                    )-2-(acetoxymethyl)-6-(4-(((5-(4-chlorophenyl)pyrazolo[1,5-\n                    <jats:italic>a<\/jats:italic>\n                    ]pyrimidin-7-yl)oxy)methyl)-1\n                    <jats:italic>H<\/jats:italic>\n                    -1,2,3-triazol-1-yl)tetrahydro-2\n                    <jats:italic>H<\/jats:italic>\n                    -pyran-3,4,5-triyl triacetate demonstrates the best inhibitory effects against MCF-7 cells (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u200915.3\u00a0\u00b5M) in all derived compounds. These results align with our docking analysis and structure\u2013activity relationship (SAR) investigations, further validating the in-vitro outcomes. This work not only underscores the synthetic utility of our devised protocol but also highlights the promising potential of these glycohybrids as candidates for further anticancer therapeutic exploration.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-50202-4","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T10:05:25Z","timestamp":1704362725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Copper-catalyzed synthesis of pyrazolo[1,5-a]pyrimidine based triazole-linked glycohybrids: mechanistic insights and bio-applications"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-8836","authenticated-orcid":false,"given":"Ghanshyam","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-5692","authenticated-orcid":false,"given":"Ashish","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-5742","authenticated-orcid":false,"given":"Vinay Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintam","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-6247","authenticated-orcid":false,"given":"Ram","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"50202_CR1","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1021\/cr400270z","volume":"114","author":"S Schenone","year":"2014","unstructured":"Schenone, S., Radi, M., Musumeci, F., Brullo, C. & Botta, M. Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: An old scaffold as a new tool for medicinal chemistry and chemical biology studies. Chem. Rev. 114, 7189\u20137238 (2014).","journal-title":"Chem. Rev."},{"key":"50202_CR2","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.2174\/1385272825666210531103927","volume":"25","author":"A Khanna","year":"2021","unstructured":"Khanna, A., Dubey, P. & Sagar, R. Exploiting microwave-assisted organic synthesis (MAOS) for accessing bioactive scaffolds. Curr. Org. Chem. 25, 2378\u20132456 (2021).","journal-title":"Curr. Org. Chem."},{"key":"50202_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41420-020-00366-z","volume":"7","author":"A Chaurasiya","year":"2021","unstructured":"Chaurasiya, A. et al. Pathogen induced subversion of NAD+ metabolism mediating host cell death: A target for development of chemotherapeutics. Cell Death Discov. 7, 10 (2021).","journal-title":"Cell Death Discov."},{"key":"50202_CR4","doi-asserted-by":"publisher","DOI":"10.1055\/a-2157-9100","author":"VK Mishra","year":"2023","unstructured":"Mishra, V. K., Tiwari, G., Khanna, A., Tyagi, R. & Sagar, R. Efficient synthesis of chirally enriched 1H-Imidazo[1,2-b]pyrazole- and 4H-Imidazo[1,2-b][1,2,4]triazole-based bioactive glycohybrids. Synthesis https:\/\/doi.org\/10.1055\/a-2157-9100 (2023).","journal-title":"Synthesis"},{"key":"50202_CR5","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1016\/j.ejmech.2009.03.042","volume":"44","author":"OM Ahmed","year":"2009","unstructured":"Ahmed, O. M., Mohamed, M. A., Ahmed, R. R. & Ahmed, S. A. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Eur. J. Med. Chem. 44, 3519\u20133523 (2009).","journal-title":"Eur. J. Med. Chem."},{"key":"50202_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s13738-021-02319-4","volume":"19","author":"AS Hassan","year":"2022","unstructured":"Hassan, A. S., Morsy, N. M., Awad, H. M. & Ragab, A. Synthesis, molecular docking, and in silico ADME prediction of some fused pyrazolo[1,5-a]pyrimidine and pyrazole derivatives as potential antimicrobial agents. J. Iran. Chem. Soc. 19, 521\u2013545 (2022).","journal-title":"J. Iran. Chem. Soc."},{"key":"50202_CR7","doi-asserted-by":"publisher","first-page":"9697","DOI":"10.1021\/acs.jmedchem.5b00771","volume":"58","author":"E Pesci","year":"2015","unstructured":"Pesci, E. et al. Novel hits in the correction of \u0394F508-cystic fibrosis transmembrane conductance regulator (CFTR) protein: Synthesis, pharmacological, and ADME evaluation of tetrahydropyrido[4,3-d]pyrimidines for the potential treatment of cystic fibrosis. J. Med. Chem. 58, 9697\u20139711 (2015).","journal-title":"J. Med. Chem."},{"key":"50202_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejmech.2013.04.029","volume":"64","author":"WM Al-Adiwish","year":"2013","unstructured":"Al-Adiwish, W. M. et al. Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles. Eur. J. Med. Chem. 64, 464\u2013476 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"50202_CR9","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3390\/molecules24214009","volume":"24","author":"AM Alsaedi","year":"2019","unstructured":"Alsaedi, A. M., Farghaly, T. A. & Shaaban, M. R. Synthesis and antimicrobial evaluation of novel pyrazolopyrimidines incorporated with mono-and diphenylsulfonyl groups. Molecules 24, 4009 (2019).","journal-title":"Molecules"},{"key":"50202_CR10","first-page":"100028","volume":"4","author":"A Ballesteros-Casallas","year":"2022","unstructured":"Ballesteros-Casallas, A. et al. Synthesis of 2,7-diarylpyrazolo [1,5-a] pyrimidine derivatives with antitumor activity. Theoretical identification of targets. Eur. J. Med. Chem. Rep. 4, 100028 (2022).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"50202_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.fjps.2016.08.004","volume":"2","author":"NSM Ismail","year":"2016","unstructured":"Ismail, N. S. M., Ali, G. M. E., Ibrahim, D. A. & Elmetwali, A. M. Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. Future J. Pharm. Sci. 2, 60\u201370 (2016).","journal-title":"Future J. Pharm. Sci."},{"key":"50202_CR12","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1021\/acs.joc.1c01343","volume":"86","author":"J Ren","year":"2021","unstructured":"Ren, J., Ding, S., Li, X., Bi, R. & Zhao, Q. An approach for the synthesis of pyrazolo[1,5-a]pyrimidines via Cu(II)-catalyzed [3+3] annulation of saturated ketones with aminopyrazoles. J. Org. Chem. 86, 12762\u201312771 (2021).","journal-title":"J. Org. Chem."},{"key":"50202_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/jm0009383","volume":"44","author":"C Almansa","year":"2001","unstructured":"Almansa, C. et al. Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines. J. Med. Chem. 44, 350\u2013361 (2001).","journal-title":"J. Med. Chem."},{"key":"50202_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2165\/00003495-200060020-00014","volume":"60","author":"M Dooley","year":"2000","unstructured":"Dooley, M. & Plosker, G. L. Zaleplon. Drugs 60, 413\u2013445 (2000).","journal-title":"Drugs"},{"key":"50202_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1517\/13543784.14.10.1269","volume":"14","author":"DN Neubauer","year":"2005","unstructured":"Neubauer, D. N. Indiplon: The development of a new hypnotic. Exp. Opin. Investig. Drugs 14, 1269\u20131276 (2005).","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"50202_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ejmech.2016.11.019","volume":"126","author":"S Cherukupalli","year":"2017","unstructured":"Cherukupalli, S. et al. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. Eur. J. Med. Chem. 126, 298\u2013352 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"50202_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.xphs.2021.08.019","volume":"111","author":"R Barbas","year":"2022","unstructured":"Barbas, R., Llinas, A. & Prohens, R. The solid state landscape of the sildenafil drug. J. Pharm. Sci. 111, 1104\u20131109 (2022).","journal-title":"J. Pharm. Sci."},{"key":"50202_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","volume":"3","author":"A Varki","year":"1993","unstructured":"Varki, A. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3, 97\u2013130 (1993).","journal-title":"Glycobiology"},{"key":"50202_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/cr940413g","volume":"98","author":"H Lis","year":"1998","unstructured":"Lis, H. & Sharon, N. Lectins: Carbohydrate-specific proteins that mediate cellular recognition. Chem. Rev. 98, 637\u2013674 (1998).","journal-title":"Chem. Rev."},{"key":"50202_CR20","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1126\/science.1059820","volume":"291","author":"CR Bertozzi","year":"2001","unstructured":"Bertozzi, C. R. & Kiessling, L. L. Chemical glycobiology. Science 291, 2357\u20132364 (2001).","journal-title":"Science"},{"key":"50202_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/a-2130-7319","volume":"07","author":"K Singh","year":"2023","unstructured":"Singh, K., Tyagi, R., Mishra, V. K., Tiwari, G. & Sagar, R. Recent advances in the synthesis of bioactive glycohybrids via click-chemistry. SynOpen 07, 322\u2013352 (2023).","journal-title":"SynOpen"},{"key":"50202_CR22","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1021\/acs.orglett.8b01656","volume":"20","author":"C Narayana","year":"2018","unstructured":"Narayana, C., Kumari, P. & Sagar, R. Regioselective synthesis of chirally enriched tetrahydrocarbazolones and tetrahydrocarbazoles. Org. Lett. 20, 4240\u20134244 (2018).","journal-title":"Org. Lett."},{"key":"50202_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1358\/dof.2006.031.12.1049173","volume":"31","author":"S-G Sampathkumar","year":"2006","unstructured":"Sampathkumar, S.-G., Campbell, C. T., Weier, C. & Yarema, K. J. Short-chain fatty acid-hexosamine cancer prodrugs: The sugar matters. Drug Future 31, 1099\u20131116 (2006).","journal-title":"Drug Future"},{"key":"50202_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ijc.2910490117","volume":"49","author":"P Pouillart","year":"1991","unstructured":"Pouillart, P., Cerutti, I., Ronco, G., Villa, P. & Chany, C. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy. Int. J. Cancer 49, 89\u201395 (1991).","journal-title":"Int. J. Cancer"},{"key":"50202_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/a-2181-9709","author":"A Khanna","year":"2023","unstructured":"Khanna, A., Tiwari, G., Mishra, V. K., Singh, K. & Sagar, R. An efficient synthesis of natural product-inspired naphthoquinone fused glycohybrids and their in-silico docking studies. Synthesis https:\/\/doi.org\/10.1055\/a-2181-9709 (2023).","journal-title":"Synthesis"},{"key":"50202_CR26","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1039\/C7OB03186F","volume":"16","author":"P Kumari","year":"2018","unstructured":"Kumari, P., Narayana, C., Dubey, S., Gupta, A. & Sagar, R. Stereoselective synthesis of natural product inspired carbohydrate fused pyrano[3,2-c]quinolones as antiproliferative agents. Org. Biomol. Chem. 16, 2049\u20132059 (2018).","journal-title":"Org. Biomol. Chem."},{"key":"50202_CR27","doi-asserted-by":"crossref","unstructured":"Kumari, P., Narayana, C., Tiwari, G. & Sagar, R. In Carbohydrates in Drug Discovery and Development 451\u2013479 (Elsevier, 2020).","DOI":"10.1016\/B978-0-12-816675-8.00011-7"},{"key":"50202_CR28","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1016\/j.apsb.2022.05.020","volume":"12","author":"X Cao","year":"2022","unstructured":"Cao, X. et al. Carbohydrate-based drugs launched during 2000\u20132021. Acta Pharm. Sin. B 12, 3783\u20133821 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"50202_CR29","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1039\/C9NJ03288F","volume":"43","author":"P Kumari","year":"2019","unstructured":"Kumari, P. et al. Synthesis of new triazole linked carbohybrids with ROS-mediated toxicity in breast cancer. New J. Chem. 43, 18590\u201318600 (2019).","journal-title":"New J. Chem."},{"key":"50202_CR30","doi-asserted-by":"publisher","first-page":"13985","DOI":"10.1039\/C8NJ01395K","volume":"42","author":"P Kumari","year":"2018","unstructured":"Kumari, P. et al. Stereoselective synthesis of carbohydrate fused pyrano[3,2-c]pyranones as anticancer agents. New J. Chem. 42, 13985 (2018).","journal-title":"New J. Chem."},{"key":"50202_CR31","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1038\/s41598-020-63377-x","volume":"10","author":"P Kumari","year":"2020","unstructured":"Kumari, P. et al. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents. Sci. Rep. 10, 6660 (2020).","journal-title":"Sci. Rep."},{"key":"50202_CR32","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1073\/pnas.1220220110","volume":"110","author":"RW Gantt","year":"2013","unstructured":"Gantt, R. W., Peltier-Pain, P., Singh, S., Zhou, M. & Thorson, J. S. Broadening the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis. Proc. Natl. Acad. Sci. 110, 7648\u20137653 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"50202_CR33","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1021\/jm8006257","volume":"51","author":"Y-S Lin","year":"2008","unstructured":"Lin, Y.-S. et al. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. J. Med. Chem. 51, 7428\u20137441 (2008).","journal-title":"J. Med. Chem."},{"key":"50202_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bmcl.2006.11.008","volume":"17","author":"D-Z Liu","year":"2007","unstructured":"Liu, D.-Z., Sinchaikul, S., Reddy, P. V. G., Chang, M.-Y. & Chen, S.-T. Synthesis of 2\u2032-paclitaxel methyl 2-glucopyranosyl succinate for specific targeted delivery to cancer cells. Bioorg. Med. Chem. Lett. 17, 617\u2013620 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"50202_CR35","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","volume":"34","author":"KR Hande","year":"1998","unstructured":"Hande, K. R. Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34, 1514\u20131521 (1998).","journal-title":"Eur. J. Cancer"},{"key":"50202_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-0348-9146-2_8","volume":"33","author":"H St\u00e4helin","year":"1989","unstructured":"St\u00e4helin, H. & Von Wartburg, A. From podophyllotoxin glucoside to etoposide. Prog. Drug Res. 33, 169\u2013266 (1989).","journal-title":"Prog. Drug Res."},{"key":"50202_CR37","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10637-010-9425-3","volume":"29","author":"M Gui","year":"2011","unstructured":"Gui, M. et al. D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase II\u03b1. Investig. New Drugs 29, 800\u2013810 (2011).","journal-title":"Investig. New Drugs"},{"key":"50202_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00001813-200602000-00006","volume":"17","author":"J Kluza","year":"2006","unstructured":"Kluza, J., Mazinghien, R., Irwin, H., Hartley, J. A. & Bailly, C. Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer Drugs 17, 155 (2006).","journal-title":"Anticancer Drugs"},{"key":"50202_CR39","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1039\/c3sc22205e","volume":"4","author":"EC Calvaresi","year":"2013","unstructured":"Calvaresi, E. C. & Hergenrother, P. J. Glucose conjugation for the specific targeting and treatment of cancer. Chem. Sci. 4, 2319\u20132333 (2013).","journal-title":"Chem. Sci."},{"key":"50202_CR40","doi-asserted-by":"publisher","first-page":"dmm040410","DOI":"10.1242\/dmm.040410","volume":"12","author":"A Shivappagowdar","year":"2019","unstructured":"Shivappagowdar, A. et al. A small bioactive glycoside inhibits epsilon toxin and prevents cell death. Dis. Models Mech. 12, dmm040410 (2019).","journal-title":"Dis. Models Mech."},{"key":"50202_CR41","doi-asserted-by":"publisher","first-page":"32858","DOI":"10.1039\/D3RA05986C","volume":"13","author":"G Tiwari","year":"2023","unstructured":"Tiwari, G., Khanna, A., Mishra, V. K. & Sagar, R. Recent developments on microwave-assisted organic synthesis of nitrogen- and oxygen-containing preferred heterocyclic scaffolds. RSC Adv. 13, 32858\u201332892 (2023).","journal-title":"RSC Adv."},{"key":"50202_CR42","doi-asserted-by":"publisher","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","volume":"116","author":"J Shelton","year":"2016","unstructured":"Shelton, J. et al. Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs. Chem. Rev. 116, 14379\u201314455 (2016).","journal-title":"Chem. Rev."},{"key":"50202_CR43","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/ange.200454078","volume":"116","author":"P Wu","year":"2004","unstructured":"Wu, P. et al. Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew. Chem. 116, 4018\u20134022 (2004).","journal-title":"Angew. Chem."},{"key":"50202_CR44","doi-asserted-by":"publisher","first-page":"7638","DOI":"10.1021\/acs.chemrev.0c00920","volume":"121","author":"AK Agrahari","year":"2021","unstructured":"Agrahari, A. K. et al. Cu(I)-catalyzed click chemistry in glycoscience and their diverse applications. Chem. Rev. 121, 7638\u20137956 (2021).","journal-title":"Chem. Rev."},{"key":"50202_CR45","doi-asserted-by":"publisher","first-page":"16803","DOI":"10.1021\/acs.langmuir.9b02704","volume":"35","author":"C Narayana","year":"2019","unstructured":"Narayana, C., Kumari, P., Tiwari, G. & Sagar, R. Triazole linked N-acetylglucosamine based gelators for crude oil separation and dye removal. Langmuir 35, 16803\u201316812 (2019).","journal-title":"Langmuir"},{"key":"50202_CR46","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1021\/acs.orglett.8b00433","volume":"20","author":"G Gu","year":"2018","unstructured":"Gu, G. et al. Enantioselective and diastereoselective Ir-catalyzed hydrogenation of \u03b1-substituted \u03b2-ketoesters via dynamic kinetic resolution. Org. Lett. 20, 1888\u20131892 (2018).","journal-title":"Org. Lett."},{"key":"50202_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536 (2017).","journal-title":"Nat. Chem. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50202-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T14:02:12Z","timestamp":1704636132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50202-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50202-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3533489\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}